Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and PK of FDL169 in Healthy Subjects and CF
NCT02767297Phase 2Completed
- Sponsor
- Flatley Discovery Lab
- Start
- Apr 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of FDL169 in cystic fibrosis (CF), sponsored by Flatley Discovery Lab. Started Apr 2016; status: completed.
02
Drugs
FDL169
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02767297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767297.